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dimentional	 culturing	 technique	 and	 a	 novel	 polyelectrolyte	 multilayer	 (PEM)	 coating	
approach.	 Concave	 agarose	 micro-wells	 were	 used	 to	 culture	 robust	 pancreatic	 beta	 cell	
spheroids	that	enhanced	cell-cell	contact.	Additionally,	the	novel	PEM	coating	using	Ca2+	pre-
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through	 glucose	 transporter	 2,	 	 (2,3)	 glucose	 is	 metabolised	 to	 generate	 ATP,	 (4,5)	
increase	 in	ATP	causes	closure	of	 the	KATP	 	channel,	 followed	by	depolymerisation	of	
beta	cell	membrane,	(6,7)	initiation	of	Ca2+	channels,	(8)	release	of	insulin	by	exocytosis
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Figure	 3-1:	 Schematic	 illustration	 of	 immunoisolated	 pancreatic	 beta	 cells	 within	 a	 semi-
permeable	 membrane.	 The	 polymeric	 semipermeable	 membrane	 allows	 transfer	 of	
oxygen	and	nutrients,	while	protects	the	inner	cells	by	restricting	entry	of	immune	cells
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external	 cross-linking	 gelation.	 (a)	 Coaxial	 airflow	 dripper,	 (b)	 electrostatic	 bead	
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Figure	 4-2:	 Schematic	 illustration	 of	 light	 pass	 on	 a	 confocal	 laser	 scanning	 microscope,	
adopted	from	..................................................................................................................	52	




M	 (P>0.05),	 (d)	 Gel	 hardening	 time	 5-20	min	 (P>0.05)	 (D).	 	 Results	 are	 presented	 as	
means±	 S.D.	 (number	 of	microparticles=	 20).	 In	 each	 experiment,	 a	 single	 processing	
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Figure	4-4:	Production	of	alginate	microcapsules	utilising	vibrational	nozzle	technology	(a)	and	




vibrational	 nozzle	 and	 conventional	 extrusion	 technique,	 respectively	 (n=110	
microcapsules).	...............................................................................................................	59	
Figure	4-6:	Diameters	and	morphologies	of	microparticles	produced	with	the	vibrating	nozzle	
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(b)	 Image	 showing	 the	 three	dimensional	 distribution	of	 encapsulated	 cells	within	 an	
ix	
	












on	day	7;	 Insulin	 release	was	normalized	against	 1000	 cells.	 (n=3),	 (*,	 **	P<0.05).	 (b)	
Stimulation	 index	 of	 encapsulated	 cells	 on	 days	 7,	 and	 14;	 SI	 value	 shows	 the	 ratio	
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Figure	 5-7:	 Evaluation	 of	 encapsulated	 cell	 viability	 in	 fluidised	 versus	 static	 culture.	 (a)	
Unmerged	two-dimensional	confocal	micrographs	of	live	cells	(calcein	AM	marker:	green	














approach	 using	 calcium	 pre-conditioning,	 reported	 in	 this	 study,	 compared	 with	 the	
conventional	PEM	coating	method	...............................................................................	103	
Figure	 6-3:	 Direct	 versus	 indirect	 immunofluorescent	 assay.	 For	 direct	method,	 one	 single	






Figure	 6-5:	 Formation	 of	 uniform	 MIN-6	 spheroids.	 (a)	 Schematic	 illustration	 of	 cell	












micro-wells	 (a)	 versus	 flat-bottomed	plate	 (b)	on	day	7	using	 fluorescent	microscope.	
Cells	were	stained	with	calcein	AM	(green:	live	cells)	and	PI	(red:	dead	cells).	Scale	bars	
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Figure	 6-8:	MIN-6	 spheroids	morphology.	 (a)	 Direct	 immunofluorescent	 staining	 of	MIN-6	
spheroids	with	Actin-Red	555	(F-actin	probe,	red)	and	DAPI	(cell	nuclei	probe,	blue)	for	









Confocal	 images	 of	 live/dead	 analysis	 was	 quantified	 with	 imageJ	 software,	 (n=10	
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The	 pancreas	 is	 a	 complex	 organ	 consisting	 of	 several	 different	 types	 of	 endocrine	 and	
exocrine	 cells,	 among	 which	 pancreatic	 beta	 cells	 are	 responsible	 for	 secreting	 insulin	 to	






Currently,	 insulin	 therapy	 is	 the	most	 common	 treatment	 for	 type	 I	 diabetes.	Maintaining	
normal	 blood	 glucose	 levels	 using	 exogenous	 insulin,	 however,	 requires	 several	 daily	
injections	and	frequent	blood	glucose	monitoring	[4-6].	Despite	the	relative	success	of	insulin	





from	 cadaveric	 donors	 was	 reported	 in	 1974	 [9,	 10].	 Major	 challenges	 facing	 the	
transplantation	of	the	whole	pancreas	or	 isolated	pancreatic	 islets	are	the	invasive	surgical	
procedure,	the	lack	of	sufficient	donors,	the	reduced	function	of	transplanted	tissue	within	a	






To	 address	 the	 problem	 with	 the	 administration	 of	 immunosuppressant	 drugs,	 cell	
encapsulation	has	emerged	to	provide	a	strategy	for	immunoprotection	of	pancreatic	islets	
[11,	12].	In	the	last	two	decades,	significant	interest	has	been	developed	in	the	application	of	
microencapsulation	 technology	 for	 cell-based	 therapies	 [13].	 Primarily,	 in	 an	 encapsulated	
system,	a	semi-permeable	polymeric	membrane	surrounds	a	single	or	small	group	of	cells	[14,	
15].	 This	 approach	 could	 be	 a	 promising	 alternative	 to	 achieve	 real-time	 blood	 glucose	
regulation	 by	 transplanting	 microencapsulated	 insulin	 secreting	 cells	 within	 a	 polymeric	
microcarrier	 [5].	 The	 semi-permeable	 membrane	 should	 allow	 bi-directional	 diffusion	 of	






application	 of	 this	 method	 has	 been	 impeded	 by	 several	 issues,	 including	 poor	
revascularisation	 of	 the	 encapsulated	 cells	 after	 implantation,	 and	 the	 large	 diameter	 of	
microcapsules	typically	within	400-800	µm,	which	results	in	the	large	graft	volume	compared	
with	the	size	of	transplantation	site	[10,	20].	Moreover,	the	large	size	of	the	capsules	expressly	









approaches	 include	 defeating	 host	 rejection	 by	 providing	 complete	 immunoisolation	 of	
encapsulated	 cells	 even	 from	small	molecules,	 such	as	 cytokines.	 	 Furthermore,	 long-term	
viability	and	function	of	encapsulated	cells	might	be	obtained	using	engineering	concepts	to	






















hand,	 type	 2	 diabetes	 (T2D)	 is	 generally	 associated	 with	 obesity	 and	 insulin	 resistance	 in	





world’s	 fifth-highest	 rate	of	 children	aged	0	–	14	 years	diagnosed	with	T1D	and	 it	 place	a	
tremendous	financial	burden	on	both	the	government	and	individuals	[1,	23,	25].	Up	to	now	













and	 apart	 from	 recent	 achievements	 in	 formulating	 more	 effective	 exogenous	 insulin,	
maintaining	normal	blood	glucose	levels	during	the	day	remains	a	big	challenge	for	patients.	
More	importantly,	 frequent	high	blood	glucose	 levels	can	 lead	to	secondary	complications,	
including	 cardiovascular	 and	 kidney	 disease,	 blindness,	 lower	 limb	 amputation,	 and	 even	
death	[1,	12,	26].	Providing	minute-to-minute	blood	glucose	regulation	can	prevent	such	late	
complications	and	hence	improve	patients’	quality	of	life.	As	a	result,	it	has	become	a	chief	




















physical	 activity	 can	 affect	 insulin	 requirement.	 Consequently,	 treatment	 based	 on	 insulin	






can	 increase	 the	 risk	 of	 diabetes	 complications.	 The	 severity	 of	 these	 complications	
emphasises	the	necessity	of	alternative	treatments	for	patients	suffering	from	T1D.	
2.2.2 Pancreatic	islet	transplantation	
Another	 treatment	 for	 T1D	 is	 pancreatic	 islet	 transplantation,	 which	 is	 currently	 only	
performed	 for	 T1D	 patients	 under	 severe	 conditions	 with	 frequent	 incidences	 of	
hypoglycaemia	and	those	who	have	already	received	kidney	transplantation	[31,	32].	Since	










requires	 less	 invasive	 surgery	 than	 other	 major	 transplantations,	 the	 successful	 clinical	
application	of	 this	approach	has	been	 limited	by	several	major	 issues	 [18].	Notably,	during	
isolation	of	pancreatic	islets,	cells	lose	their	vascularised	network	as	well	as	their	extracellular	
matrix	 (ECM)	 connection	 with	 other	 cells	 and	 this	 reduces	 the	 levels	 of	 viability	 in	 the	
harvested	cells.	Therefore	approximately	2-3	donors	are	required	for	each	patient	receiving	
an	 islet	 transplant	 [18,	23].	 This	places	an	upper	 limit	on	 the	number	of	patients	 that	 can	
receive	 this	 therapy,	 and	hence	more	 studies	are	 required	 to	 increase	 the	efficacy	of	 islet	
isolation	as	well	as	regeneration	of	pancreatic	beta	cells	using	alternative	approaches,	such	as	















as	 trypsinogen,	pancreatic	 lipase,	 and	amylase	 [38].	While,	 the	endocrine	 cells	 (pancreatic	
islets)	comprises	four	main	different	cell	types,	each	responsible	for	the	secretion	of	a	specific	
hormone,	 including	 glucagon	 producing	 α-cells,	 insulin	 producing	 β-cells,	 somatostatin	
producing	γ-cells,	and	pancreatic	polypeptide	secreting	PP-cells	[39,	40].	Each	islet	contains	
approximately	 1000-2000	 single	 cells.	 After	 the	 discovery	 of	 pancreatic	 islets	 by	 Paul	
Langerhans	 in	 1869,	 they	 	 have	 been	 named	 “islet	 of	 Langerhans”	 [36]	 and	 in	 diabetes	
research,	 an	 islet	 with	 an	 average	 diameter	 of	 150	 µm	 is	 regarded	 as	 a	 standard	 islet	
equivalent	(IEQ)	[40,	41].	Among	different	cells	in	pancreatic	islets,	beta	cells	are	the	only	cells	
responsible	 for	the	secretion	of	 insulin.	 	Also,	studies	on	pancreatic	 islets	have	shown	that	









Moreover,	 these	 specific	 three-dimensional	 (3D)	 islets	 contain	 dense	 fenestrated	
microvascular	networks,	and	consequently	the	blood	flow	to	the	islets	is	nearly	ten	times	more	
than	the	blood	flow	to	the	exocrine	pancreas.	This	high	level	of	vascularisation	enables	proper	
oxygenation	and	helps	 facilitate	 the	ability	of	beta	cells	 to	sense	changes	 in	blood	glucose	
levels	[37,	44,	45].	Notably,	the	secretion	of	insulin	from	pancreatic	beta	cells	relies	on	various	
factors,	 including	 the	 availability	 of	 nutrients,	 hormones,	 parasympathetic	 neurons	 (for	


















































beta	 cells	 [49,	51].	 	 The	 initiation	of	 insulin	 secretion	 relies	on	various	glucose	 sensors	 for	
measuring	 the	 level	 of	 circulating	 glucose.	Notably,	 among	 several	 glucose	 transporters	 in	
different	mammalian	 cells	 (GLUT	 1-	 GLUT	 13),	 glucose	 transporter	 2	 (GLUT-2)	 is	 the	 only	
transporter	expressed	in	pancreatic	beta	cells	for	glucose	entry	[37,	49].	As	illustrated	in	Figure	









insulin	 from	 stored	 granules	 due	 to	 exocytosis	 [1,	 37,	 49].	 On	 the	 contrary,	 at	 low	 blood	
glucose	levels,	KATP	channels	open	and	cause	K
+	to	flow	out	through	the	membrane,	which	then	








































































beta	 cells	 from	 other	 sources	 could	 become	 a	 promising	 approach	 to	 address	 the	 lack	 of	
donated	pancreases	[18,	56].		
Pluripotent	 stem	 cells	 (PSCs)	 have	 been	 explored	 as	 an	 alternative	 to	 beta	 cells	 as	 a	
consequence	 of	 their	 capability	 to	 develop	 into	 any	 cell	 type	 [2].	 	 Predominantly,	
differentiation	of	human	embryonic	stem	cells	(hESCs),	human	induced	pluripotent	stem	cells	





addition,	 the	clinical	application	of	 this	approach	has	been	hindered	by	 the	risk	of	 tumour	
development	 after	 transplantation,	 and	 the	 current	 ethical	 issues	 in	 the	 application	 of	
embryonic	stem	cells	[6].	
In	2016,	research	by	the	Melton	lab	at	Harvard	stem	cell	institute	led	to	the	production	of	new	
beta	 cells,	 which	 compared	 with	 the	 previously	 reported	 studies,	 were	 closer	 to	 mature	
human	pancreatic	beta	cells	based	on	their	ability	to	secrete	insulin	in	response	to	glucose	
stimulation	in	vitro	[58].		Although	further	progress	in	the	current	differentiation	protocols	is	





Even	with	 the	possibility	of	utilising	 stem	cells	 to	overcome	the	 insufficiency	of	pancreatic	





the	 encapsulated	 cells	 from	 direct	 contact	 with	 host’s	 immune	 system.	 This	 enables	 the	




the	 surrounding	 environment	 by	 restricting	 their	 contact	 with	 cytotoxic	 T-cells	 and	
inflammatory	cytokines,	the	encapsulated	material	should	allow	the	free	passage	of	oxygen,	
nutrients,	 insulin	 and	 other	 cell	 products	 and	wastes	 [12,	 18]	 (Figure	 3-1).	 Since	 the	 first	
attempt	 in	the	1960s	to	encapsulate	cells	 in	a	semi-permeable	polymeric	membrane	there	


























Extravascular	 devices	 are	 implanted	 outside	 the	 vasculature,	 which	 reduces	 surgical	 risk	
during	 implantation	 in	 comparison	 with	 intravascular	 devices	 [12].	 For	 implantation	 of	
extravascular	devices	in	both	human	and	animal	models	(rats,	and	monkeys),	the	peritoneal	
cavity	and	subcutaneous	sites	have	been	most	commonly	used	[29].	So	far,	different	natural	
or	 synthetic	materials	 including,	 a	 copolymer	of	 sodium	methyl	 sulfonate	and	acrylonitrile	
(AN69)	[59],	a	copolymer	of	polyvinyl	chloride	and	polyacrylonitrile	(PAN-PVC)	[26],	agarose,	
and	polyvinyl	alcohol	have	been	used	for	manufacturing	these	macro-devices	[12].	
	Despite	 partial	 success	 in	 using	 extravascular	 devices	 in	 maintaining	 normoglycaemia	
(between	2	to	9	weeks)	without	immunosuppressive	drugs,	several	major	drawbacks	remain	









Intravascular	 devices	were	 created	 to	 overcome	 the	mass	 transport	 limitations	 associated	
with	extravascular	devices.	As	the	name	suggests,	intravascular	macro-devices	are	implanted	
directly	 into	 the	arterial	 vessel,	hence	 they	have	 the	advantage	of	being	connected	 to	 the	
patient’s	 blood	 circulating	 system	 [29].	 This	 results	 in	 increased	 diffusion	 of	 oxygen	 and	
glucose	to	the	encapsulated	islets	when	compared	with	extravascular	macro-devices	[12,	18,	
26].	




Since	 then,	 similar	 results	 have	 been	 reported,	 which	 demonstrate	 that	 the	 majority	 of	
technologies	 are	 not	 efficacious	 because	 of	 surgical	 risk	 during	 implantation	 and	 the	
occurrence	of	thrombosis,	especially	at	the	interface	between	the	implanted	membrane	and	





The	 advent	 of	 micro	 technology	 for	 encapsulating	 enzymes	 in	 1964,	 led	 to	 the	 broader	
application	 of	 this	 technology	 for	 cell-based	 therapeutic	 research	 [5].	 In	 general,	
microcapsules	provide	a	semipermeable	polymeric	structure	with	the	size	of	200-1500	µm	for	
enveloping	single	or	small	clusters	of	cells	[60].	The	spherical	shape	and	small	dimension	of	








would	 be	 unaffected.	 This	makes	 these	 cell	 carrier	 devices	more	 favourable	 compared	 to	
macroencapsulated	devices	[29].	
The	 first	 relatively	 successful	 attempt	 in	 encapsulating	 pancreatic	 beta	 cells	 in	 alginate	
microparticles	 and	 their	 transplantation	 into	 the	 peritoneal	 cavity	 of	 a	 diabetic	 rat	 was	
reported	 by	 Lim	 and	 Sun	 in	 1980	 [19].	 Since	 then,	 the	 application	 of	 microcapsules	 for	
protecting	pancreatic	beta	cells	in	search	of	an	alternative	treatment	for	T1Ds	has	become	a	





et	 al.	 [62]	 reported	 transplantation	 of	 encapsulated	 pancreatic	 islets	 within	 alginate	
microcapsules	for	a	patient	with	T1D	who	had	already	received	kidney	transplantation.	Their	
study	resulted	in	nearly	9	months	of	insulin	independence,	however,	this	result	was	achieved	
while	 the	patient	was	on	a	 low	dose	of	 immunosuppressive	drugs	 [62].	More	examples	of	


































































































cells	 with	 low	 proliferation	 capacities,	 including	 pancreatic	 islets	 isolated	 from	 cadaveric	
donors,	as	these	cells	are	more	susceptible	to	toxicity	during	encapsulation	[70].	Moreover,	






glycol	 (PEG)	[73],	polyvinyl	alcohol	 (PVA)	 [73],	alginate-poly	amino	acids-alginate	(APA)	 [5],	
agarose	 [17,	 73,	 74],	 sol-gel	 silica	 [17],	 chitosan	 [17,	 73],	 poly-l-lysine	 (PLL)	 [60],	 poly-l-
ornithine	 (PLO)	 [60],	 polyethylene-glycol	 and	 poly-lactic-co-glycolic	 acid	 (PEG-PLGA)	 [74],	
28	
	








Application	 of	 various	 gelation	 techniques	 and	 polymer	 concentration	 can	 lead	 to	 the	
formation	of	hydrogel	microparticles	with	different	levels	of	homogeneity.	The	gel	polymer	
can	 be	 evenly	 distributed	 through	 the	 particle	 or	 alternatively	 may	 form	 a	 shell	 with	 a	
polymer-free	core.	This	 feature	of	hydrogels	 is	another	 important	reason	for	their	growing	
application	in	cell-based	approaches,	which	allows	controllable	permeability	and	stability	of	







Alginate	 is	 an	 anionic	 polysaccharide	 extracted	 from	 fast-growing	 brown	 algae	 or	 certain	
29	
	







































within	 the	polymeric	 structure	of	 alginate	are	 shielded	and	 can	no	 longer	 attach	 to	water	
molecules	[8].		
Formation	 of	 alginate	 gel	 occurs	 by	 ionic	 bonding	 between	 the	 divalent	 cations	 and	 the	
polymer	chains	[76].	The	degree	to	which	alginate	tends	to	bind	with	different	cations	varies	
according	to	the	following	trend:	Mg2+<	Ca2+<	Sr2+<	Ba2+	[80].	Despite	Ba2+	having	the	greatest	
affinity	 to	 the	 polymeric	 chain,	 its	 application	 is	 restricted	 due	 to	 the	 toxicity	 of	 barium,	
especially	in	the	case	of	in	vivo	studies.	So	far,	Ca2+	has	been	the	most	widely	used	cross-linker	






















polymeric	 drop	 is	 released	 into	 the	 cross-linking	 medium	 [83].	 Despite	 the	 simplicity	 of	





The	 coaxial	 airflow	dripper,	 electrostatic	bead	generator,	 jet	 cutter,	 and	vibrational	nozzle	
technology	are	among	the	existing	strategies	for	the	formation	of	alginate	microparticles	with	
higher	uniformity	[85,	86].	All	of	these	techniques	are	solely	based	on	mechanical	processes	






head.	 Finally,	 in	 vibrational	 nozzle	 technology,	 at	 a	 specific	wavelength,	 the	 laminar	 liquid	
stream	breaks	apart	 into	droplets	under	vibrational	 force	 [5,	84]	 (Figure	3-4).	Although	all	
these	devices	are	superior	to	the	conventional	extrusion	technique	by	allowing	the	formation	






















































devices	 in	 generating	 alginate	 microparticles.	 Coaxial	 airflow	 and	 electrostatic	 bead	
generators	were	shown	to	be	more	applicable	to	produce	alginate	particles	using	both	low	
and	high	alginate	concentrations	compared	with	the	other	two	technologies.	On	the	other	
hand,	 the	 application	 of	 the	 vibrational	 nozzle	 technology	 and	 jet	 cutter	 can	 increase	 the	






forward	 to	 clinical	 transplantation	 of	 encapsulated	 pancreatic	 islets.	 Poor	 function	 and	


















the	 microcapsules	 semi-permeable	 membrane	 affects	 physiological	 kinetics	 of	 insulin	
secretion	 in	 respond	 to	 abrupt	 changes	 in	 glucose	 concentrations	 [4].	 Consequently,	








disadvantage	of	using	the	 liver	 is	 the	 lack	of	a	sufficiently	well	vascularised	network	 in	the	




of	 vascularisation	 can	 result	 in	 cell	 dysfunction	 and	 hypoxia	 due	 to	 low	 oxygenation.	 As	
discussed	 earlier,	 this	 could	 be	 even	 more	 problematic	 for	 cells	 encapsulated	 within	 a	
semipermeable	membrane	[18,	89].	For	encapsulated	pancreatic	 islets,	which	are	of	 larger	
volume	compared	with	the	non-encapsulated	islets,	the	intraperitoneal	site	has	been	the	most	
studied	 site.	 The	 intraperitoneal	 site	 can	 provide	 easy	 access	 to	 the	 transplanted	 system;	
however,	 it	 still	 lacks	 sufficient	 vascularisation.	 Previous	 trials	 have	 also	 shown	 that	




transplantation	 of	 both	 encapsulated	 and	 non-encapsulated	 pancreatic	 islets	 [60].	 So	 far,	
reports	 have	 shown	 that	 these	 transplantation	 sites	 suffer	 from	 various	 drawbacks.	 For	
instance,	the	eye	and	brain	can	be	regarded	as	immunologically-privileged	sites,	meaning	that	
they	 can	 tolerate	 antigens	 without	 evoking	 inflammatory	 responses,	 but	 both	 sites	 lack	
sufficient	space	for	the	transplantation	of	a	relatively	large	amount	of	encapsulated	cells	with	
an	average	size	of	500	µm	[12,	60].	Therefore,	convincing	clinical	transplantation	of	pancreatic	






Polyelectrolyte	 multilayer	 (PEM)	 coating	 also	 known	 as	 layer-by-layer	 (LBL)	 self-assembly	
technique	is	a	recent	strategy	with	the	potential	to	protect	cells	from	immune	responses	[90,	








Schematic	 of	 polyelectrolyte	 multilayer	 coating	 procedure	 on	 a	 surface	 with	 initial	









Examples	 include	 biosensors,	 drug	 delivery	 systems,	 cell	 surface	 modifications,	 and	
membranes	such	as	wound	healing	films	[90,	93,	95].	
Apart	from	the	presence	of	relatively	weak	Van	der	Waals	interactions	and	hydrogen	bonding	
between	 the	 polyelectrolytes,	 the	 formation	 of	 the	 multilayers	 dominantly	 relies	 on	
electrostatic	 interactions	 between	 the	 oppositely	 charged	 polymers	 [92].	 Selective	
permeability	 of	 polyelectrolyte	 multilayers	 can	 be	 manipulated	 by	 choosing	 a	 different	
number	 of	 bilayers,	 as	 well	 as	 varying	 polyelectrolyte	 combinations	 [93].	 Two	 main	
mechanisms	have	been	reported	regarding	the	growth	of	bilayers	on	a	charged	surface.	The	













bilayers	 is	 achievable	 under	 mild	 temperature	 and	 pH	 conditions.	 Often	 during	 the	 PEM	
coating,	there	is	no	requirement	for	cross-linker	or	toxic	solvents	[92].		
The	 PEM	 coating	 was	 first	 developed	 for	 flat	 charged	 surfaces;	 however,	 later	 on,	 its	








physical	 property	 depends	 highly	 on	 the	 polyelectrolyte	 layer	 composition.	 Up	 until	 now	
several	 synthetic	 and	 natural	 polyelectrolyte	 pairs	 have	 been	 investigated	 in	 cell-based	
studies,	 such	 as	 PEG-lipid	 and	 PVA,	 PLL-g-PEG-(biotin)	 and	 streptavidin	 [97],	 polystyrene	





inflammatory	 response	 triggers	by	 the	 cationic	polymer.	Apart	 from	encapsulation	of	 cells	
41	
	
using	 PEM	 coating,	 this	method	has	 also	 been	 applied	 in	 surface	modification	 studies.	 An	
example	includes	the	formation	of	PAA/PAH	multilayers	with	linear	growth	by	Moussallem,	et	
al.	 [99].	 This	work	 investigated	 the	 cellular	 behaviour	 of	 A7r5	 rat	 smooth	muscle	 cells	 on	





In	vitro	mammalian	cell	 culture	dates	back	 to	100	years	ago.	However,	 since	 then	modern	
biotechnological	approaches	in	cell	culture	methods	has	been	investigated	to	keep	up	with	
high	 demand	 for	 biological	 products	 [100].	 One	 important	 example	 is	 the	 large-scale	













Reactors	 for	biological	applications	 can	be	categorised	 into	main	 six	 types:	 (1)	 stirred-tank	
bioreactors,	 (2)	 pneumatically	 agitated	 bioreactors,	 (3)	 rotary	 bioreactors,	 (4)	 hollow	 fibre	
bioreactors,	(5)	fixed-bed	bioreactors,	and	(6)	fluidised	bed	bioreactors	[103].	
	In	 stirred-tank	 bioreactors	 and	 pneumatically	 agitated	 bioreactors,	 sufficient	 mixing	 of	




and	 are	 mostly	 desirable	 for	 adherent	 cell	 types	 [104].	 Fixed-bed	 bioreactors	 are	 usually	
preferred	for	cells	being	immobilised	on	the	surface	of	microcarriers.	In	this	case,	fixed-bed	







and	 cultivating	 adherent	mammalian	 cells	 [103].	Up	 to	now,	 several	mathematical	 studies	
using	 computational	 fluid	 dynamic	 have	 been	 reported	 for	 different	 types	 of	 bioreactors	
43	
	





viability	 and	 insulin	 secretion	 ability	 of	 encapsulated	 beta	 cells	 within	 two	 different	
encapsulating	strategies,	as	well	as	cultivation	of	encapsulated	cells	in	static	versus	fluidised	
system.	 For	 both	 encapsulating	 systems	 investigated	 in	 this	 thesis,	 generation	 of	
immunoisolated	systems	with	less	than	250	µm	was	aimed	to	enhance	cell	survival	through	
facilitated	diffusion	of	oxygen	and	nutrients.	In	this	regard,	vibrational	technology	with	a	high	
production	 rate,	 as	 well	 as	 its	 potential	 for	 producing	 microcapsules	 with	 narrow	 size	










• Investigation	 of	 the	 effect	 of	 fluidised	 cultivation	 on	 the	 viability	 and	 function	 of	
endocrine	cells.	


























[11,	 12].	 In	 recent	 times,	 important	 advances	 within	 this	 field	 have	 been	 made	 through	
microstructural	manipulations	leading	to	larger	surface	area	to	volume	ratio,	increased	oxygen	
and	nutrient	diffusion	rate,	and	also	access	to	more	implantation	sites	by	injection	[5,	16].		
There	 is	a	 range	of	methods	 for	 the	encapsulation	of	 living	cells	 in	alginate	microparticles.	
Successful	 cell	 encapsulation,	 however,	 requires	 that	 the	 resulting	 capsules	 be	 of	
homogeneous	size	and	distribution.	It	is	also	important	to	use	a	method	of	manufacture	that	
is	mild	and	rapid	to	reduce	the	loss	in	potency	of	the	pancreatic	beta	cells	[83,	107-109].		












(Figure	4-1).	 The	vibrating	 instrument	 consists	of	a	 feed	 line	connected	 to	a	 syringe	and	a	
nozzle.	The	 internal	diameter	of	the	nozzles	used	 in	this	study	was	80-120	µm.	A	receiving	
cross-linking	solution	(100	mM	CaCl2)	was	placed	at	a	distance	of	20	cm	from	the	nozzle	head.	
In	 vibrating	 nozzle	 technology,	 a	 laminar	 fluid	 jet	 will	 naturally	 break	 into	 droplets	 at	 a	


















































dissolved	 in	 sterile	 deionised	 water	 (1%w/v).	 The	 cross-linking	 solution	 was	 prepared	 by	
dissolving	granular	calcium	chloride	(Sigma,	UK)	 in	deionised	water	(100	mM).	All	solutions	























gelation,	 the	 capsules	were	washed	 twice	with	 PBS	 and	DMEM	 to	 remove	 any	 remaining	
calcium	ions	from	the	encapsulated	particles.	
4.2.6 Evaluation	of	microcapsules	size	over	time	
Alginate	 microparticles	 with	 and	 without	 cells	 were	 prepared	 (section	 4.2.5)	 and	 kept	 in	








The	 integrity	 of	 alginate	microcapsules	 through	 the	 injection	 process	was	 examined	 using	
needles	of	different	gauges.	Briefly,	200	µL	of	alginate	microcapsules	suspended	 in	DMEM	
were	 injected	through	an	18G,	21G,	and	23G	needle.	For	each	needle	size,	the	 injection	of	





















































The	 viability	 of	 β-TC-6	 cells	 encapsulated	 in	 alginate	 microparticles	 was	 assayed	 using	 a	





(indicator	 for	 viable	 cells)	 were	 chosen.	 Upon	 addition	 of	 non-fluorescent	 calcein	 AM	
(C46H46N2O23),	it	converts	to	calcein	(C30H26N2O13)	with	a	green	fluorescence	owing	to	the	cell’s	
intracellular	activity	(peak	excitation=	495	nm,	peak	emission=	515	nm).	In	contrast	to	calcein	













was	 added	 to	 microcapsules	 suspended	 in	 supplemented	 DMEM	 for	 4	 h	 under	 growth	
conditions.	 Fluorescence	 was	 read	 at	 570	 nm	 excitation	 and	 600	 nm	 emission	 using	 a	






To	 investigate	 the	 permeability	 of	 the	 1%w/v	 alginate	 microcapsules	 to	 immunologically	










non-encapsulated	and	encapsulated	cells	 in	 response	 to	changes	 in	glucose	was	measured	
[115,	 116].	 Briefly,	 samples	with	1x106	 cells/mL	were	washed	and	pre-incubated	 in	Krebs-







was	 collected	 for	 the	 insulin	 assay.	 The	 supernatant	 obtained	 by	 centrifugation	 of	 the	
dissolved	particles	was	then	diluted	to	 the	appropriate	range	based	on	the	assay	standard	
curve.	 The	 secreted	 insulin	 was	 measured	 using	 a	 rat/mouse	 insulin	 enzyme-linked	
immunosorbent	 assay	 (ELISA)	 kit	 (Millipore,	 USA),	 and	 the	 colorimetric	 reaction	 was	












a	 CyQUANT	 cell	 counting	 kit	 (Invitrogen,	 UK),	 which	 expresses	 strong	 fluorescence	 after	
binding	 to	 the	 cellular	 nucleic	 acid	 (maximum	 excitation=	 480,	maximum	 emission=	 520).	








the	 GSIS	 assay.	 One-way	 analysis	 of	 variance	 (One-way	 ANOVA)	was	 used	 to	 identify	 any	
significance	 difference	 between	 the	 means	 of	 the	 independent	 groups.	 Furthermore,	




In	 the	 production	 of	 alginate	 beads	 with	 the	 vibrating	 nozzle	 technology,	 an	 increase	 in	
alginate	concentration	from	0.5	to	2%w/v	resulted	in	an	increase	in	average	bead	diameter	
from	220	to	800	μm	(P-value	<0.01)	(Figure	4-3:	a).	Increasing	alginate	concentration	beyond	












M,	 hardening	 time=10	 min),	 (b)	 Frequency	 of	 vibrating	 nozzle	 800-1800	 Hz	 (P<0.01)	
(alginate	 concentration=1%,	 CaCl2=0.1	 M,	 hardening	 time=10	 min),	 (c)	 Cross-linked	
solution	 concentration	 0.05-1	M	 (P>0.05)	 (alginate	 concentration=1%,	 frequency=1000	







These	 outcomes,	 in	 parallel	 with	 visual	 observation	 suggested	 that	 an	 interdependent	
behaviour	 between	 the	 mentioned	 parameters	 and	 polymer	 flow	 rate	 exist	 during	 bead	




frequent	 blockage	 of	 the	 nozzle	with	 80	 µm	diameter	 (minimum	 available	 size	within	 the	
device)	 with	 the	 polymer	 solution,	 the	 120	 µm	 nozzle	 was	 chosen	 for	 generation	 of	
microparticles	throughout	this	chapter.	Figure	4-4	shows	the	results	from	optimised	acellular	
alginate	particles	with	an	average	diameter	of	200	μm	and	 less	 than	9%	 relative	 standard	
deviation.	
	
Production	of	alginate	microcapsules	utilising	vibrational	nozzle	 technology	 (a)	 and	 (b)	

































Comparison	 between	 size	 distributions	 of	 alginate	 microparticles	 prepared	 with	



























Diameters	 and	 morphologies	 of	 microparticles	 produced	 with	 the	 vibrating	 nozzle	
technology.	 Change	 in	 alginate	 microparticle	 diameter	 with	 time,	 (a)	 Alginate	







































































































showing	 the	 three-dimensional	 distribution	 of	 encapsulated	 cells	 within	 an	 alginate	
microparticle	using	confocal	laser	scanning	microscopy,	and	Z-stack	imaging	(stacks	of	2-





























class	 II	 antigens	 on	 the	 surface	 of	 beta	 cells.	 Compared	 with	 the	 control	 sample,	 cells	
encapsulated	in	alginate	were	successfully	protected	from	the	antibody.	No	fluorescence	was	





















Confocal	 images	 of	 cells	 after	 being	 exposed	 to	 FITC-mouse	 antibody.	 (a)	 Non-











days	 7	 and	 14	 by	 culturing	 samples	 in	 a	 series	 of	 low	 (2	mM),	 and	 high	 (20	mM)	 glucose	
concentration.	 After	 7	 days,	 cells	 encapsulated	 in	 the	 alginate	 microcapsules	 showed	 an	
insulin	 secretion	 index	 (SI)	 greater	 than	 1.	Moreover,	 cells	 secreted	 15.2	 and	 39.3	 insulin	
(ng/mL)	under	low	and	high	glucose	conditions,	respectively,	which	was	similar	to	the	amount	
of	insulin	secreted	from	the	non-encapsulated	cells	(17.8	and	37.6	insulin	(ng/mL)	at	low	and	















Encapsulation	 of	 living	 cells	 in	 polymeric	 carriers	 has	 long	 promised	 to	 enable	 cell-based	
therapies	 by	 camouflaging	 the	 encapsulated	 cells	 from	 the	 host’s	 immune	 system.	 In	 this	
work,	 β-TC-6	 cells	were	 encapsulated	 in	 alginate	microparticles	 utilising	 a	 vibrating	 nozzle	
technology.	 In	 comparison	 to	 conventional	 encapsulation	 techniques	 that	 often	 fail	 to	





cell	 suspension	 in	 polymer),	 and	 in	 situ	method	 for	 production	 of	microcapsules	with	 the	
capability	of	generating	relatively	uniform	micro-droplets	with	a	well-defined	diameter.	
Herein,	 the	 entire	 encapsulation	 process	 was	 conducted	 at	 room	 temperature	 under	
physiological	 pH.	 Preliminary	 observations	 showed	 that	 for	 the	 optimisation	 of	 the	
experimental	parameters	 several	 factors,	 such	as	 the	nozzle,	 vibration	 frequency,	polymer	






diameter	 of	 particles	 increased	 as	 a	 result	 of	 hydrogel	 swelling	 behaviour	 (Figure	 4-6:	 a).	
However,	 the	 particles	 showed	 a	 decrease	 from	 day	 18,	 possibly	 due	 to	 the	 degradation	
process,	as	has	been	reported	by	previous	studies	[76].	Moreover,	during	this	study	no	obvious	
changes	 in	 the	 surface	morphology	 of	 alginate	microparticles	 were	 observed.	 Overall,	 no	
obvious	difference	in	diameter	of	microcapsules	overtime	with	and	without	encapsulated	cells	
was	 found,	 demonstrating	 that	 the	 encapsulated	 cells	 had	 no	 significant	 effect	 on	 the	
degradation	rate	of	alginate	microparticles.	
Cell	viability	analysis	demonstrated	no	significant	effect	of	vibration	frequency	on	viability	of	










To	 get	 a	 more	 complete	 image	 of	 cell	 survival	 and	 the	 metabolic	 activity	 of	 β-TC-6	 cells	
embedded	in	alginate	hydrogel,	a	spectrophotometric-Alamar	blue	assay	was	performed	at	




the	 other	 hand,	 our	 long-term	 in	 vitro	 study	 revealed	 a	 significant	 reduction	 in	 insulin	
secretion	ability	of	encapsulated	cells	after	2	weeks	(Figure	4-13).		
In	 an	 attempt	 to	 further	monitor	 endocrine	 pancreatic	 cells	 reduced	 capacity	 in	 secreting	









within	 the	 pancreatic	 islets.	 In	 the	 pancreas,	 beta	 cells	 function	 also	 depends	 on	 several	
regulatory	signals	from	other	tissues,	including	the	liver,	intestinal	endocrine	cells,	fat,	and	the	
gut.	 Furthermore,	 interactions	with	 glucagon	 releasing	-cells	 and	 sympathetic	 neurones	
enhance	the	ability	of	beta	cells	to	stimulate	insulin	secretion	and	achieve	normoglycaemia	
[23-25].	 Therefore,	 in	 chapter	 6	 of	 this	 thesis,	 a	 detailed	 study	 was	 performed	 by	 the	
























to	 transplantation	 [13].	 A	 promising	methodology	 to	 address	 the	 issues	with	 storage	 and	
distribution	of	a	therapeutically	relevant	number	of	encapsulated	cells	between	 laboratory	
and	clinical	site	could	be	through	storage	and	expansion	in	bioreactors	[13].	Bioreactors	not	
only	 provide	 clinical	 accessibility	 but	 also	 lower	 the	 contamination	 risk	 associated	 with	
conventional	 culturing	methods.	 Economically,	 these	 devices	 are	 regarded	 as	 a	more	 cost	
effective	approach	for	cell-based	therapeutic	studies	compared	to	standard	cell	culture	flasks,	
owing	to	less	frequent	media	changes	[13,	101,	102].	












agitated	 bioreactors,	 their	 application	 for	 the	 cultivation	 of	 encapsulated	 cells	 has	 been	
hampered	since	they	cannot	be	used	for	encapsulated	cells.	The	non-applicability	of	hollow	
fibre	 bioreactors	 for	 microcapsules	 is	 mainly	 due	 to	 the	 existence	 of	 a	 semi-permeable	
membrane	(fibre	wall)	between	the	encapsulated	cells	and	the	fluid,	resulting	in	relatively	low	
diffusion	of	nutrients	[121].	Alternatively,	fluidised	bed	bioreactors	can	provide	direct	contact	
between	 encapsulated	 cells	 and	 cell	 culture	 medium	 or	 physiological	 fluids.	 In	 these	
bioreactor	 systems,	 the	 difference	 between	 the	 density	 of	 encapsulated	 particles	 and	 the	
medium	enables	the	suspension	of	particles	with	an	upward	flow	of	the	medium	and	hence	
encapsulated	 cells	 will	 float	 throughout	 the	 column	 without	 the	 need	 for	 aeration	 or	
mechanical	agitation	[105,	121].	
The	present	work	investigates	the	feasibility	of	applying	a	fluidised	bed	bioreactor	design	for	
the	 cultivation	 of	 pancreatic	 insulin	 secreting	 beta	 cells	 encapsulated	 in	 uniform	 alginate	
microcapsules.	The	performance	of	 the	 fluidised	bed	bioreactor	was	 studied	by	evaluating	

























the	culture	medium.	A	bioreactor	 (provided	by	Dr.	Ellis	at	 the	University	of	Bath)	with	 the	
following	 dimensions	 was	 used	 in	 this	 study:	 cylinder	 height=100	 mm	 (with	 attached	



































collected	 from	 the	 fluidised	 bed	 bioreactor	 and	 T-75	 cell	 culture	 flask	 (control).	 Fifty	
microcapsules	were	randomly	captured	using	light	microscope	connected	to	a	digital	camera,	
and	their	diameter	was	evaluated	using	Image	J	software.	To	indicate	the	effect	of	fluidisation	






























statically	 incubated	 for	 1	 h	 with	 low	 (2	 mM)	 glucose	 concentration	 in	 KRBH+	 0.1%	 BSA	
followed	by	the	addition	of	high	(20	mM)	glucose	concentration	in	KRBH+	0.1%	BSA	as	the	
stimulator	and	samples	incubated	for	another	hour.	For	each	incubation	period,	the	samples	
were	 collected	 during	 GSIS	 for	 quantitative	 evaluations.	 The	 collected	 samples	were	 then	
diluted	to	the	appropriate	range	based	on	the	assay	standard	curve	(1:100	ratio).	Secreted	
insulin	 was	measured	 using	 a	 rat/mouse	 insulin	 ELISA,	 and	 the	 colorimetric	 reaction	 was	
quantified	using	a	plate	spectrophotometer	at	450	nm.	CyQUANT	cell	counting	kit	was	utilised	
to	normalise	the	ELISA	results	to	the	number	of	encapsulated	cells	in	each	sample.	The	insulin-
stimulated	 index	 (SI)	was	 calculated	 from	 the	 ratio	of	 insulin	 secreted	under	high	and	 low	
glucose	stimulation. 
5.3 Statistical	analysis	
Results	 are	 presented	 as	 mean	 ±	 standard	 error	 of	 the	 mean	 unless	 otherwise	 stated.	




Fluidisation	 of	 cell	 embedded	 microcapsules	 within	 the	 bioreactor	 was	 initiated	 by	 the	




rate,	 forced	 upward	 movement	 of	 alginate	 particles,	 followed	 by	 the	 horizontal	 and	






Quantitative	 evaluation	 of	 fluidisation	 using	 bed	 expansion	 parameter.	 (a)	 Calibration	
curve	of	the	peristaltic	pump	utilised	for	pumping	the	cell	culture	medium	through	the	
bioreactor	 column.	 (b)	 Quantitative	 characterisation	 of	 fluidisation	 quality	 using	 bed	

























































































Besides	 2-dimensional	 micrographs	 of	 groups	 of	 live/dead	 fluorescently	 stained	 cells	 in	
















































within	 a	 group	 of	 alginate	 microcapsules.	 (b)	 Unmerged	 two-dimensional	 confocal	






































































































































A	 variety	 of	 bioreactors	 has	 been	 studied	 for	 a	 broad	 range	 of	 applications,	 including	
biopharmaceutical,	bacteria	and	yeast	culture,	enzyme	production,	scaffolds,	and	mammalian	
cell	culture	(mainly	for	hepatocytes,	and	bone	marrow	stromal	osteoblasts)	[106,	124,	125].	
However,	 there	 are	 fewer	 published	 studies	 regarding	 the	 experimental	 application	 of	




perfusion	 of	 cell	 culture	 medium	 through	 the	 bioreactor	 column,	 which	 provides	 direct	
contact	between	the	encapsulated	cells	and	the	medium	for	the	exchange	of	nutrients	and	
oxygen	[126].		
Unlike	 plant	 cells,	 mammalian	 cells	 do	 not	 have	 cell	 wall	 [127],	 which	 make	 them	more	
vulnerable	to	shear	forces	imposed	by	mechanical	mixing	in	pneumatically,	and	stirred-tank	
bioreactors.	Hence,	application	of	a	 fluidised	bioreactor,	based	on	 the	upward	 flow	of	 the	
medium	and	its	circulation	through	the	column,	completely	removes	the	need	for	mechanical	
mixing	 with	 impeller	 or	 aeration,	 and	 this	 improves	 survival	 of	 cells	 with	 higher	 shear	
sensitivity	[100,	128].	Fluidised	bioreactors	have	a	very	simple	design	(Figure	5-1)	with	 low	
manufacturing	cost,	especially	compared	to	the	more	complex	hollow	fibre	bioreactors.	This	
chapter	 introduced	 a	 new	 application	 of	 fluidised	 bioreactors	 to	 overcome	 the	 existing	
transplantation	challenge	by	providing	a	handling	method	between	manufacturing	and	clinical	





Herein,	 characterisation	 of	 fluidisation	 quality	within	 bioreactor	 column	was	 evaluated	 by	
measuring	 bed	 expansion	 versus	 medium	 flow	 rates	 (Figure	 5-2).	 The	 application	 of	 the	
vibrational	encapsulator,	discussed	in	more	detail	in	Chapter	four,	allowed	the	generation	of	




throughout	 the	 entire	 bioreactor	 column	 (Figure	 5-3).	 This	was	 also	 confirmed	 evaluating	
encapsulated	cell	viability	and	insulin	secretion	sensitivity.	
Additionally,	the	feasibility	of	applying	a	fluidised	bed	bioreactor	for	the	cultivation	of	cells	




cellular	microparticles	 cultured	 in	 fluidised	 bed	 bioreactor	 or	 T-75	 flask.	 In	 Figure	 5-5	 the	
increase	observed	in	the	average	diameter	of	alginate	microcapsules	from	day	1	to	day	7	was	
expected	due	to	the	swelling	behaviour	of	alginate	hydrogel,	which	has	been	reported	both	in	
chapter	 four	 of	 this	 thesis	 and	 previous	 studies	 [76].	 This	 result	 in	 parallel	 with	 low	
microcapsule	 breakage	 (Figure	 5-6)	 suggested	 the	 promising	 performance	 of	 fluidised	





Herein,	 characterisation	 of	 fluidisation	 quality	within	 bioreactor	 column	was	 evaluated	 by	
measuring	 bed	 expansion	 versus	 medium	 flow	 rates	 (Figure	 5-2).	 The	 application	 of	 the	
vibrational	encapsulator,	discussed	in	more	detail	in	Chapter	four,	allowed	the	generation	of	




throughout	 the	 entire	 bioreactor	 column	 (Figure	 5-3).	 This	was	 also	 confirmed	 evaluating	
encapsulated	cell	viability	and	insulin	secretion	sensitivity.	
Additionally,	the	feasibility	of	applying	a	fluidised	bed	bioreactor	for	the	cultivation	of	cells	




cellular	microparticles	 cultured	 in	 fluidised	 bed	 bioreactor	 or	 T-75	 flask.	 In	 Figure	 5-5	 the	
increase	observed	in	the	average	diameter	of	alginate	microcapsules	from	day	1	to	day	7	was	
expected	due	to	the	swelling	behaviour	of	alginate	hydrogel,	which	has	been	reported	both	in	
chapter	 four	 of	 this	 thesis	 and	 previous	 studies	 [76].	 This	 result	 in	 parallel	 with	 low	
microcapsule	 breakage	 (Figure	 5-6)	 suggested	 the	 promising	 performance	 of	 fluidised	
bioreactor	used	 in	here	 for	 the	 cultivation	of	 encapsulated	MIN-6	 cells	within	1%	alginate	
95	
	












harmful	effect	on	cell	 viability.	Additionally,	determination	of	MIN-6	cells	ability	 to	 remain	
functional	in	fluidised	culture	revealed	that	encapsulated	cells	cultivated	within	the	bioreactor	
exhibited	higher	 insulin	 sensitivity	 compared	 to	 the	control	group.	Notably,	 comparison	of	
results	obtained	from	GSIS	assay	on	day	1	(Figure	5-9)	versus	day	7	(Figure	5-10),	showed	the	
insulin-stimulated	index	of	encapsulated	MIN-6	cells	in	static	culture	was	slightly	reduced	from	
2.4	 to	 2.3.	 Whereas,	 in	 the	 case	 of	 the	 fluidised	 bed	 bioreactor,	 in	 conjugation	 with	
encapsulated	cells	ability	in	secreting	more	amount	of	insulin	on	day	7,	the	value	of	the	insulin-
stimulated	index	was	also	exhibited	an	increasing	trend	from	3.4	to	3.7.	
An	 explanation	 for	 enhanced	 insulin	 sensitivity	 of	 pancreatic	 MIN-6	 cells	 in	 the	 fluidised	











































to	 the	 transplantation	 site,	 results	 in	 an	 unfavourable	 ratio	 between	 encapsulated	 cells	
volume	and	overall	capsule	volume	[10,	20].	Consequently,	the	large	distance	between	the	




based	on	 the	 alternate	 deposition	 of	 anionic	 and	 cationic	 polyelectrolytes	 onto	 a	 charged	
surface,	 and	was	 discussed	 in	more	 detail	 in	 chapter	 three	 of	 this	 thesis	 [130,	 131].	 This	
approach	 limits	 the	gap	between	the	cells	and	 the	surrounding	environment	 resulting	 in	a	







In	 this	 chapter,	 alginate	 (anionic	 polyelectrolyte)	 and	 PLL	 (polyelectrolyte	 with	 a	 positive	
charge)	were	applied	to	build	polyelectrolytes	bilayers.	Owing	to	the	negative	charge	of	cells,	
PEM	coating	is	typically	initiated	by	the	deposition	of	a	cationic	polymer.	However,	previous	
studies	 have	 shown	 that	 when	 cationic	 polymers	 are	 used	 in	 direct	 contact	 with	 cells,	 it	
increases	 the	 possibility	 of	 host	 inflammatory	 responses	 and	 cytotoxic	 behaviour	 [8,	 98].	






cells	 encapsulated	within	 the	matrix	 of	 one	microparticle.	 This	 was	 addressed	 in	 here	 by	
evaluating	 the	 effect	 of	 utilising	 3-dimensional	 cell	 culturing	 technique	 to	 create	 beta	 cell	
spheroids	 in	search	of	higher	cell-cell	 interactions	prior	to	PEM	coating.	Then,	the	possible	









































PBS,	 respectively.	 All	 solutions	were	 sterile	 filtered	 using	 a	 0.22	 μm	 syringe	 filter	 and	 UV	
102	
	
sterilised	overnight.	Contrary	 to	 the	conventional	 layer-by-layer	polyelectrolyte	deposition,	
before	starting	the	coating	process	cell	spheroids	were	first	suspended	in	200	μL	of	CaCl2	(100	
mM)	 (Figure	 6-2).	 After	washing	with	 PBS,	 200	 μL	 of	 alginate	was	 added	 to	minimise	 the	
potential	 toxicity	 of	 direct	 contact	 between	 cells	 surface	 and	 cationic	 polymer	 (PLL).	















A	 schematic	 illustration	 representing	 the	 difference	 between	 a	 novel	 PEM	 coating	






























































h.	 After	 washing	 in	 PBS,	 fixed	 cells	 were	 stained	 with	 Actin-red	 555	 (F-actin	 Probe,	 Life	
Technologies,	UK)	for	30	min,	followed	by	several	washing	steps	with	PBS.	Cell	nuclei	were	









peak:	 525	 nm).	 Briefly,	 cell	 spheroids	 with	 and	 without	 coating	 layers	 were	 prepared	 as	
described	in	section	6.2.4.	Fifteen	MIN-6	spheroids	were	randomly	selected	from	each	group,	
and	 100	 μL	 of	 2%	 BSA	 in	 HBSS	 (blocking	 buffer)	 were	 added	 to	 the	 samples.	 Cells	 were	
incubated	for	15	min	at	37	̊C	with	1	μL	of	FITC-	antibody.	Samples	were	then	washed	twice	
with	HBSS	and	0.1%	Tween-20	to	remove	any	excess	antibody.	The	coated	and	non-coated	














During	 the	GSIS	 assay,	 the	 cultured	 supernatant	was	 collected	 for	 quantitative	 evaluation	




between	 pairs	 of	 groups.	One-way	 analysis	 of	 variance	 (ANOVA)	was	 used	 to	 identify	 any	
significant	difference	between	the	means	of	independent	groups.	Furthermore,	a	Bonferroni	




























Formation	 of	 uniform	 MIN-6	 spheroids.	 (a)	 Schematic	 illustration	 of	 cell	 aggregation	























Comparison	 between	 MIN-6	 spheroids	 cultured	 on	 different	 surfaces.	 (a)	 and	 (b)	
formation	of	MIN-6	cell	spheroids	cultured	on	flat-bottomed	plate	and	agarose	concave	























	As	 expected,	 fluorescence	 signals	 from	 the	 filamentous	 actin	 (F-actin)	 cytoskeleton,	














Coating	 of	 MIN-6	 spheroids	 was	 achieved	 by	 subsequent	 layering	 of	 oppositely	 charged	








6	 spheroids	 coated	 directly	 with	 PLL.	 After	 8	 days	 of	 culture,	 quantitative	 analysis	 of	 the	
stained	cells	revealed	a	significant	difference	(p<0.01)	between	the	viability	of	cells	that	were	
pre-coated	(89	±	6%)	and	those	with	an	initial	layer	of	PLL	(64	±	11%)	(Figure	6-9).	The	viability	







Evaluation	 of	 viability	 of	 MIN-6	 spheroids	 coated	 with	 four	 bilayers	 of	 PLL/ALG.	 (a)	
Confocal	microscopic	images	of	live	(green)	and	dead	(red)	stained	cells	coated	with	initial	
layer	of	alginate	during	the	pre-coating	step.	(b)	Cell	spheroids	coated	with	PLL	as	the	first	

















































































































To	 investigate	 the	 permeability	 of	 coated	 MIN-6	 spheroids	 to	 immunologically	 relevant	
molecules,	samples	were	exposed	to	FITC-mouse	antibody,	which	can	then	target	the	antigens	

























Figure	 6-15,	 after	 24	 h	 exposure	 to	 cytokines,	 the	 metabolic	 activity	 of	 non-coated	 cell	
spheroids	was	notably	reduced	to	55±2.5	RFU	(P-value<0.01).	Moreover,	the	response	of	MIN-
6	spheroids	to	cytokines	after	the	addition	of	one	bilayer	of	polyelectrolytes	was	only	slightly	


















































concentration	 (P-value	 <	 0.05)	 (Figure	 6-16:	 b).	 In	 addition,	 a	 comparison	 between	 the	

























































In	 this	 study,	 we	 have	 demonstrated	 the	 formation	 of	 stable	 and	 uniformly	 sized	 MIN-6	
spheroids	 using	 agarose-based	 concave	 micro-wells.	 The	 prepared	 spheroids	 were	 then	
immunoisolated	with	ALG	and	PLL	using	a	novel	coating	approach.	Up	to	now,	several	groups	
have	 developed	 polydimethylsiloxane-based	 micro-molds	 for	 creating	 cell	 aggregates,	
however,	 using	 this	 substrate	 requires	 further	 steps	 for	modification	 of	well	 surfaces	 and	







of	 aggregated	 cells	 formed	 on	 a	 flat-bottomed	 plate	 varied	 between	 50	 and	 250	 μm	 and	















volume	between	 the	encapsulated	cells	and	 the	 surrounding	environment	utilising	various	




phosphoro-choline	 to	 reduce	 their	 toxicity	 and	 inflammatory	 responses	 [114,	 144,	 145].		
Herein,	we	chose	PLL	and	ALG	as	the	cationic	and	anionic	polymers,	respectively.	However,	as	
a	novel	approach	to	reduce	the	toxicity	of	PLL,	cells	were	first	suspended	in	100	mM	of	CaCl2,	
which	enhanced	 the	 formation	of	 a	 layer	of	ALG	prior	 to	 the	 addition	of	 PLL	on	 the	 cell’s	
surface.		
















Although	maintaining	 a	 high	metabolic	 activity	 and	 survival	 rate	 of	 the	 encapsulated	 cells	
could	 increase	 the	 longevity	 of	 transplanted	 cells,	 complete	 success	 in	 pancreatic	 islet	
implantation	 relies	 upon	 efficient	 immunoisolation	 of	 the	 cells	 from	 recipient	 immune	
responses.	In	this	regard,	to	gain	a	better	insight	into	the	coating	approach	established	in	this	
study,	both	coated	and	non-coated	cells	were	exposed	to	FITC-mouse	antibody.	The	images	
from	spheroids	were	 captured	 through	 the	Z-axis	using	 confocal	microscopy	 (Figure	6-14).	
Observation	showed	a	notable	prohibition	of	FITC	antibody	 from	attaching	 to	MHC	class	 II	
antigens	on	the	surface	of	coated	beta	cells	in	comparison	to	the	non-coated	cells.	
Previous	studies	have	shown	that	release	of	the	three	main	pro-inflammatory	cytokines	(IL-
1β,	 TNF-α,	 and	 IFN-γ)	 from	 activated	 T-cells	 and	 macrophages	 could	 be	 responsible	 for	
dysfunction	of	beta	cells	by	inducing	over	expression	of	inducible	nitric	oxide	synthase	(iNOS)	
[37,	 146].	 In	 the	 present	 study,	we	 evaluated	whether	 the	 coated	 cells	 could	 prevent	 the	
129	
	
diffusion	of	 cytokines	 to	MIN-6	 spheroids.	 Figure	6-15	emphasised	 that	deposition	of	 pre-
coating	 layer	and	 four	bilayers	of	PLL/ALG	was	effective	 in	 inhibiting	cytokine	damage	and	
hence	increasing	cell	survival	compared	with	non-coated	spheroids.	
We	 further	 demonstrated	 the	 MIN-6	 spheroid’s	 ability	 to	 sense	 the	 changes	 in	 glucose	























investigating	novel	approaches	 to	 improve	 the	 survival	of	 immunoisolated	pancreatic	beta	






metabolically	active	and	 retain	 their	viability	 for	30	days	 in	vitro.	 In	addition,	CLSM	
images	illustrated	an	even	distribution	of	the	cells	between	the	centre	and	the	inner	
surface	of	the	alginate	microcapsules.	
• Results	 from	the	 in	vitro	glucose	stimulation	assay	revealed	reduction	 in	the	 insulin	
secretion	ability	of	beta	cells	after	14	days	when	compared	to	their	insulin	sensitivity	
on	day	7.	To	further	explore	this	observation,	a	3D	culture	method	was	developed	with	

















• In	 addition	 to	minimal	microparticle	 damage,	 high	 beta	 cell	 viability	 and	 enhanced	
insulin	 sensitivity	was	 demonstrated	 through	 the	use	of	 a	 fluidised-bed	bioreactor.	
Suggesting	that	culture	of	encapsulated	cells	within	this	relatively	small	system	could	
provide	 a	 simplistic	 solution	 for	 the	 current	 challenges,	 which	 exist	 in	 transferring	
encapsulated	cells	from	laboratories	to	clinical	sites.	This	approach	could	offer	a	cost	
effective	 solution	 utilising	 a	 sterile	 fluidised	 system	 that	 eliminates	 the	 need	 for	












MIN-6	 spheroids,	 which	 allowed	 the	 addition	 of	 anionic	 polyelectrolyte	 (alginate)	
before	 the	 deposition	 of	 cationic	 polymer	 (PLL).	 This	 strategy	 was	 found	 to	 be	 an	
effective	 way	 for	 preserving	 cellular	 metabolism	 and	 viability	 compared	 with	
conventional	PEM	coating	procedures.	 
• Similar	 to	 non-coated	 beta	 cell	 spheroids,	 coated	 cell	 spheroids	 were	 shown	 to	























cells	 reported	 in	 this	 study	has	a	number	of	 improvements	when	compared	with	previous	
microencapsulation	 methods,	 including	 a	 reduction	 in	 graft	 volume,	 which	 enhanced	 the	
apparent	mass	transport	limitations.	In	addition,	cells	exhibited	a	greater	ability	to	tolerate	
direct	 exposure	 to	 the	 cationic	 polyelectrolyte.	 	 Further,	 PEM	 coating	 provides	 a	 possible	
platform	for	surface	modification	using	other	bioactive	compounds,	which	could	extend	the	





cytokines	 when	 compared	 with	 beta	 cell	 spheroids	 coated	 with	 fewer	 bilayers.	
However,	it	is	noted	that	the	optimal	number	of	bilayers	determined	from	in	vitro	data	




necessary	 to	 re-assess	 the	 number	 of	 polyelectrolyte	 bilayers	 to	 achieve	 complete	
coverage	of	cells	from	the	host’s	immune	response.		





of	 second	or	 third	 transplantation	 to	 supplement	 an	unhealthy	population	of	 cells,	
which	have	lost	their	functionality	after	post-transplantation	[64,	65,	68].	The	quantity	
of	encapsulated	cells	largely	depends	on	the	body	mass,	insulin	requirements,	choice	
of	 transplantation	 site,	 and	 the	 characteristic	 of	 the	 immunoisolated	 system	 [147].	
Therefore,	 another	 important	 investigation	 related	 to	 in	 vivo	 studies	 would	 be	
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Calcium pre-conditioning 
substitution enhances viability and 
glucose sensitivity of pancreatic 
beta-cells encapsulated using 
polyelectrolyte multilayer coating 
method
Niusha Nikravesh, Sophie C. Cox, Gurpreet Birdi, Richard L. Williams  & Liam M. Grover
Type I diabetics are dependent on daily insulin injections. A therapy capable of immunoisolating 
pancreatic beta-cells and providing normoglycaemia is an alternative since it would avoid the late 
complications associated with insulin use. Here, 3D-concave agarose micro-wells were used to culture 
robust pancreatic MIN-6 cell spheroids within 24 hours that were shown to exhibit cell-cell contact 
and uniform size (201 ± 2 µm). A polyelectrolyte multilayer (PEM) approach using alginate and poly-
l-lysine was employed to coat cell spheroids. In comparison to conventional PEM, use of a novel Ca2+ 
pre-coating step enhanced beta-cells viability (89 ± 6%) and metabolic activity since it reduced the 
toxic effect of the cationic polymer. Pre-coating was achieved by treating MIN-6 spheroids with calcium 
chloride, which enabled the adhesion of anionic polymer to the cells surface. Pre-coated cells coated 
with four bilayers of polymers were successfully immunoisolated from FITC-mouse antibody and pro-
inflammatory cytokines. Novel PEM coated cells were shown to secret significantly (P < 0.05) different 
amounts of insulin in response to changes in glucose concentration (2 vs. 20 mM). This work presents a 
3D culture model and novel PEM coating procedure that enhances viability, maintains functionality and 
immunoisolates beta-cells, which is a promising step towards an alternative therapy to insulin.
The encapsulation of cells within a polymeric semi-permeable membrane is attractive for various biomedical 
applications. In particular, this method has been studied to treat endocrine diseases, such as diabetes1. Type 1 
diabetes, also known as diabetes mellitus, is an autoimmune disease that results from the failure in glucose regu-
lation due to the destruction of pancreatic beta-cells by immune cells2. Typically insulin therapies are employed, 
however, continuous unregulated blood glucose levels can lead to a variety of secondary complications including, 
cardiovascular disease, blindness, kidney disease, and death2,3. Maintaining normoglycaemia would prevent such 
complications and improve patient’s quality of life1. A promising alternative therapy is to encapsulate beta-cells so 
that when transplanted the cells are protected from the host immune system, which would eliminate the need for 
immunosuppressant drugs. Critically this should be balanced with the diffusion of oxygen, signalling molecules, 
nutrients, and secreted products, such as insulin2,4.
Encapsulation of mammalian cells was first described by Lim and Sun, who formed alginate hydrogel micro-
capsules embedded with pancreatic islets5. Since then, the clinical application of this method has been hampered 
by various issues, such as poor revascularisation of the constructs after implantation, relatively large diame-
ter microcapsules (400–800 µm) in comparison to the transplantation site, and an unfavourable ratio between 
encapsulated cells volume and overall capsule volume6,7. The two latter obstacles are related to the large distance 
between the encapsulated cells and the surrounding environment, which results in limited mass transfer, hypoxia, 
and ultimately cell dysfunction and death1.
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A possible solution may be to coat cells with polyelectrolytes rather than embedding cells in a polymeric 
matrix. This technique, known as layer-by-layer (LBL) or polyelectrolyte multilayer coating (PEM), is based on 
the alternate deposition of anionic and cationic polymers on to a charged surface8,9. This approach limits the gap 
between the cells and the surrounding environment resulting in a shorter response time to external stimulation10, 
while retaining a coating that may prevent immune response. This may allow rapid response to changes in blood 
glucose and thereby better regulation.
Alginate is the most common and studied material for encapsulation of living cells and therapeutic agents11. 
Alginate is an anionic polymer that can form polyelectrolyte complexes in the presence of polycations, such as 
poly-l-lysine (PLL) and chitosan. PLL has been used to coat alginate beads as a way of controlling the ingress of 
biological components harmful to cell survival12,13. Owing to the negative charge of cells, PEM coating is initi-
ated by the deposition of a cationic polymer, however, previous studies have shown that when cationic polymers 
are used in direct contact with cells it increases the possibility of host inflammatory responses and cytotoxic 
behaviour1,14.
In this study, a novel pre-coating step was introduced into a conventional PEM coating method to minimise 
the influence of PLL on cell viability by conditioning the surface of cell aggregates with CaCl2, before exposure to 
PLL. The resulting spheroids were analysed with respect to viability, functionality, and immunoisolation.
Results
Formation of uniform MIN-6 spheroids. To achieve uniform aggregation of pancreatic beta-cells prior to 
the PEM coating process, dispersed MIN-6 cells were seeded on top of agarose-based micro-wells. Cell spheroids 
with uniform size and shape (92 ± 4.9 µm) were generated in the centre of the concave wells within 24 h due to 
aggregation of each cell by cell-cell contact and gravitational force (Fig. 1b). The majority of cell spheroids formed 
after one day of culture and only a few micro-wells remained vacant (<1.5%). It was discovered that 4–5 days of 
culture was the optimum time period to achieve robust spheroids, which could be easily harvested and used for 
the coating procedure.
MIN-6 spheroid morphology. Then to quantify the effect of culturing cells on 3D agarose constructs, the 
size distribution of 30 spheroids cultured on both a flat-bottomed plate (control) and concave wells were com-
pared after 7 days of culture. In the case of MIN-6 spheroids in agarose-based wells, their size range was mostly 
between 200–250 µm with an average of 201 ± 2 µm. However, for the control sample, cells exhibited a wide range 
of sizes from 50–250 µm with an average of 103 ± 49.2 µm (Fig. 2a,b,c). To gain insight in to the influence of 3D 
culture, immunofluorescent staining of actin filaments and cell nuclei were examined on day 5. As expected, 
fluorescence signals from the filamentous actin (F-actin) cytoskeleton, suggested that the MIN-6 spheroids were 
adhered to one another, forming a compact structure. DAPI staining showed a large number of freely growing 
cells on the surface of the MIN-6 spheroids (Fig. 2d).
Addition of pre-coating step increased cytocompatiblility of coated cells. Coating of MIN-6 
spheroids was achieved by subsequent layering of oppositely charged polyelectrolytes; ALG (alginate) and PLL 
(poly-l-lysine). After the pre-coating step (pre-conditioning with CaCl2 and deposition of initial ALG layer), each 
coated spheroid was formed by the alternate deposition of four bilayers (a total of 8 layers) of polyelectrolytes. For 
Figure 1. Formation of uniform MIN-6 spheroids. (a) Schematic illustration of cell aggregation within 
agarose-based micro-wells. (b) Light microscopy imaging of cell aggregation in wells during time intervals: 5, 
10 min, 4, and 24 h of post-seeding.
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all cell spheroids, ALG was chosen as the final polyelectrolyte layer. To investigate whether the pre-coating step 
was efficient in reducing the toxic effect of PLL, the viability of the pre-coated cells was compared with MIN-6 
spheroids coated directly with PLL. After 8 days of culture, quantitative analysis of the stained cells revealed a 
significant difference (p < 0.01) between the viability of cells that were pre-coated (89 ± 6%) and those with an 
initial layer of PLL (64 ± 11%) (Fig. 3c).
Furthermore, the metabolic activity of coated MIN-6 spheroids (with and without the pre-coating step) was 
compared with non-coated cells as a control (Fig. 3d). In comparison to pre-coated spheroids and non-coated 
cells, the ability of non-pre-coated spheroids to reduce the Alamar Blue reagent (metabolic activity indicator) 
was significantly reduced (p = 0.04) after 9 days of culture, possibly due to the toxicity of PLL when used in direct 
contact with MIN-6 cells; Hence in comparison to the control, the metabolic activity of cells coated with an initial 
layer of PLL was reduced by 32%, while for the cells with pre-coating step there was a smaller reduction of 13%.
Confirmation of coating on cell spheroid surfaces. To demonstrate the deposition of polyelectrolytes 
on cell spheroids, PLL labelled with Alexa Fluor-647 was used. The FITC labelled PLL was then applied to the 
final bilayer (7th layer) to enable visualisation of coated cells under confocal microscope. From cross sectional 
images obtained at distances of 10 and 30 µm from the centre of cell spheroid, using Z-stack imaging technique 
(Fig. 4a,b), the fluorescent signalling was mainly located at the peripheries of the coated cells, which indicated 
successful coating of cells with alternate deposition of polyelectrolyte layers. Also Fig. 4d and e demonstrate the 
difference in behaviour of coated and non-coated spheroids when cultured on a CellBIND tissue culture plate. 
After 7 days of culture, non-coated spheroids attached to the surface and cells covered and migrated across the 
whole area, as expected. On the contrary, coated spheroids with 4 bilayers remained suspended in the culture 
medium confirming that the entire spheroid surface was coated.
Coated MIN-6 cells excluded FITC-antibody. To investigate the permeability of coated MIN-6 spheroids 
to immunologically relevant molecules, samples were exposed to FITC-mouse antibody which can then target the 
antigens (MHC class II) that exist on the surface of pancreatic beta-cells. The fluorescence intensity emitted from 
non-coated spheroids was shown to be much greater than coated spheroids (Fig. 5). This study provided evidence 
that compared with the control (non-coated cells), pre-coating of cells with alginate followed by the deposition 
Figure 2. Comparison between MIN-6 spheroids cultured on different surfaces. (a) and (b) Morphology 
of MIN-6 cells cultured on flat-bottomed plate and agarose concave micro-wells on day 7, respectively. (c) 
Comparison between the size distribution of aggregated cells in both flat-bottomed and concave wells (n = 30 
spheroids), large chain of cell clumps formed in flat-bottomed sample were not analysed in this study (Indicated 
with an arrow). (d) Direct immunofluorescent staining of MIN-6 spheroids with Actin-Red 555 (F-actin probe) 
and DAPI (cell nuclei probe) for visualisation of cell-cell interaction using CLSM.
www.nature.com/scientificreports/
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Figure 3. Evaluation of viability and metabolic activity of MIN-6 spheroids coated with four bilayers 
of PLL/ALG. (a) Confocal microscopic images of live (calcein-AM: green) and dead (PI: red) stained cell 
spheroids coated with initial layer of alginate during the pre-coating step. (b) Cells coated with PLL as the first 
coating layer. (c) Quantitative evaluation of live/dead analysis (n = 10 spheroids) (d) Comparison between 
metabolic activity of MIN-6 coated spheroids with and without pre-coating step, and the control (non-coated 
spheroids) (n = 3), Results are presented as mean ± S.D, (*P < 0.05).
Figure 4. Monitoring the ALG/PLL coating layers on MIN-6 spheroids. (a) and (b) Z-stack cross-sections 
of coated MIN-6 spheroids with FITC-PLL obtained at 10 and 30 µm from the centre, respectively. (c) 3-D 
reconstruction of coated spheroid (Raw data from Z-stack was analysed with Imaris software). (d) and (e) Light 
Micrographs of coated and non-coated cell spheroids in response to cell-attachable surface, respectively.
www.nature.com/scientificreports/
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of four bilayers of PLL and ALG considerably protected the coated pancreatic beta-cells from attaching to the 
FITC-antibody by covering the surface of spheroids.
Coated cells exhibited higher survival after being exposed to cytokines. To further examine 
the permeability of coated spheroids against smaller molecules, a mixture of three cytokines: IL-1β (~17 KDa), 
TNF-α (~17.5 KDa), and IFN-γ (~15 KDa) was added to both non-coated and coated spheroids with 1, 2, and 4 
bilayers of polyelectrolytes. As shown in Fig. 6a, after 24 h exposure to cytokines, the viability and metabolic activ-
ity of non-coated cell spheroids were notably reduced to 55 ± 2.5 RFU (P-value < 0.01). Moreover, response of 
MIN-6 spheroids to cytokines after the addition of one bilayer of polyelectrolytes was only slightly different from 
the non-coated cells. However, deposition of four bilayers of PLL/ALG significantly reduced cytokine damage on 
pancreatic beta-cells survival rate (204 ± 3.3 RFU) in comparison with other groups (P-value < 0.01).
Coated spheroids remained responsive to the changes in glucose concentrations. After two 
weeks of culture, insulin secretion from coated and non-coated MIN-6 spheroids (n = 50) in response to glucose 
was investigated by culturing both samples in a series of basal (2 mM), and stimulatory (20 mM) glucose concen-
trations. The amount of insulin released from coated spheroids into basal glucose solution was 17.1 ± 0.1 ng/mL, 
which was significantly increased to 57.3 ± 0.4 ng/mL under a stimulatory glucose concentration (P-value < 0.05) 
(Fig. 6b). Also, comparison between the amounts of secreted insulin from both coated and non-coated spheroids 
showed no significant difference, indicating that the coated MIN-6 cells remained responsive to glucose after 
applying four bilayers of ALG/PLL.
Discussion
In this study, we have demonstrated the formation of stable and uniformly sized MIN-6 spheroids using 
agarose-based concave micro-wells. The prepared spheroids were then immunoisolated with ALG and PLL using 
a novel coating approach. Up to now, several groups have developed polydimethylsiloxane-based micro-molds 
for creating cell aggregates, however, using this substrate requires further steps for modification of well surfaces 
and preventing cell adhesion15–17. Herein, the formed beta-cell spheroids were easily detached and retrieved from 
the agarose construct without any further need for treatment with trypsin or surface modification, which was an 
advantage for preventing damage to cells during the harvesting and coating process.
Figure 5. Confocal images of MIN-6 spheroids after being exposed to FITC-mouse antibody (10 KDa). 
(a) Z-stack image of non-coated spheroid using argon laser. (b) Coated spheroid with pre-coating step and 4 
bilayers of PLL/ALG. Z-stack images were obtained at distance of 5 and 15 µm from the centre of both coated 
and non-coated spheroids.
www.nature.com/scientificreports/
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Microscopic observation followed by size analysis confirmed that the use of concave micro-wells facilitated 
the formation of uniform MIN-6 spheroids with a size range similar to pancreatic islets (150–250 µm) (Fig. 2c). 
In contrast, the diameter of aggregated cells formed on a flat-bottomed plate varied between 50 and 250 µm, and 
also resulted in accumulation of cell chains with non-uniform shape and a broad size distribution (Fig. 2a). The 
viability of these samples was notably affected and therefore such shapes are undesirable for coating. Previous 
studies have shown that culturing epithelial cells in a 3D environment could improve cell adhesion and intra-
cellular signalling by providing an additional dimension for external cell interactions18. As a result, formation of 
beta-cell spheroids were studied as a means to mimic the real tissue and cell adhesions were observed by direct 
fluorescent staining of F-actin and cell nuclei of MIN-6 spheroids (Fig. 2d).
For the past two decades, coating mammalian cells using a layer-by-layer assembly of polyelectrolytes has been 
studied as a promising approach to reduce large void volume between the encapsulated cells and the surrounding 
environment utilising various materials, including both synthetic and natural polymers9,19. However, using this 
approach and the application of positively charged polymers in direct contact with cells can be detrimental to cell 
survival and functionality13. Hence several groups have demonstrated the effect of modifying polycations with 
different materials, including poly(ethylene) glycol and phosphoro-choline to reduce their toxicity and inflamma-
tory responses19–21. Herein, we chose PLL and ALG as the cationic and anionic polymers, respectively. However, 
as a novel approach to reduce the toxicity of PLL, cells were first suspended in 100 mM of CaCl2, which enhanced 
the formation of a layer of ALG prior to the addition of PLL on the cell’s surface. Results from live/dead staining 
suggested that the coating approach used in this study, enhanced cell survival by 25% in comparison with the 
conventional LBL procedure after being coated for 8 days (Fig. 3c). Also, a possibility for the clusters of dead cells 
observed in Fig. 3b might be secretion of harmful chemicals, associated with dead cells.
Furthermore, pre-coated cells were able to maintain higher metabolic activity compared with MIN-6 sphe-
roids coated with an initial layer of PLL (Fig. 3D). Importantly, these studies confirmed that suspending cells in 
100 mM of CaCl2 during the pre-coating step did not induce harmful effect on cell viability, hence it was con-
cluded that with the described coating approach the toxic effect of PLL was reduced without any further need for 
surface or chemical modification.
The presence of polyelectrolyte layers on MIN-6 spheroids was confirmed by the means of FITC labelled PLL. 
When FITC-PLL was applied to the last bilayers, clear fluorescent emission was observed from cross sectional 
images and Z-stack 3D reconstruction of coated spheroid (Fig. 4a,b,c), suggesting the existence and successful 
deposition of polymeric layers on the surface of cell spheroids.
Although maintaining a high metabolic activity and survival rate of the encapsulated cells could increase 
the longevity of transplanted cells, complete success in pancreatic islet implantation relies upon efficient immu-
noisolation of the cells from recipient immune responses. In this regard, to gain a better insight into the coating 
approach established in this study, both coated and non-coated cells were exposed to FITC-mouse antibody. 
The images from spheroids were captured through the Z-axis using confocal microscopy (Fig. 5). Observation 
showed a notable prohibition of FITC antibody from attaching to MHC class II antigens on the surface of coated 
beta-cells in comparison to the non-coated cells.
Previous studies have shown that release of the three main pro-inflammatory cytokines (IL-1β, TNF-α, and 
IFN-γ) from activated T-cells and macrophages could be responsible for dysfunction of beta-cells by inducing 
over expression of inducible nitric oxide synthase (iNOS)22,23. In the present study, we evaluated whether the 
coated cells could prevent the diffusion of cytokines to MIN-6 spheroids. Figure 6a, emphasised that deposition of 
pre-coating layer and four bilayers of PLL/ALG was effective in inhibiting cytokine damage and hence increasing 
cell viability compared with naked spheroids.
Figure 6. (a) Viability of non-coated and coated MIN-6 spheroids with different numbers of PLL/ALG bilayers 
after being incubated with a cytokine mixture for 24 h; Results are presented as mean ± SEM (n = 4), (*P < 0.01), 
and were normalised to 1000 cells. (b) Insulin release of non-coated (control) and coated MIN-6 spheroids in 
response to glucose stimulation. Insulin release was normalized against 50 spheroids; Results are presented as 
mean ± S.D (n = 3), (*, **P < 0.05).
www.nature.com/scientificreports/
7Scientific RepoRts | 7:43171 | DOI: 10.1038/srep43171
We further demonstrated the MIN-6 spheroid’s ability to sense the changes in glucose concentration (2 Vs. 
20 mM) during the GSIS assay. For both coated and non-coated cells, increasing glucose concentration from basal 
to stimulatory, significantly increased the amount of insulin secreted by cells (Fig. 6b). Hence the data showed 
that suspending cells in CaCl2 solution during the pre-coating step followed by the addition of 4 bilayers of PLL/
ALG, did not affect MIN-6 cells in terms of insulin release.
In conclusion, we developed uniform sized and shaped MIN-6 spheroids using an agarose construct with the 
advantage of forming robust 3D cell spheroids that may be easily harvested. The feasibility of the reported novel 
calcium pre-coating approach to enhance cell survival and functionality of pancreatic beta-cells was demon-
strated using various assays. Use of this pre-coating step was found to be an effective way for preserving MIN-6 
cellular metabolism and viability compared with conventional PEM coating procedures. Similar to non-coated 
cells, coated pancreatic beta-cells allowed a rapid response to external glucose changes. Promisingly, incorpora-
tion of this pre-coating step followed by four bilayers of ALG and PLL obstructed large immunological molecules 
as well as cytokines compared to naked spheroids. In summary, this novel coating method was shown to be a 
promising immunoisolation therapy which may be utilised for the treatment of type 1 diabetes and potentially 
other endocrine diseases.
Methods
Cell culture. MIN-6 cells (AddexBio, San Diego, USA) were cultured in Dulbecco’s modified eagle medium 
(DMEM, 4500 mg/L glucose, Sigma, UK) supplemented with 15% fetal bovine serum (FBS, Sigma, UK), 2 mM 
L-glutamine (Sigma, UK) and 0.05 mM 2-mercaptoethanol (Sigma, UK)22. Since mouse pancreatic beta-cells 
have limited ability to tolerate oxidative stresses, 2-mercaptoethanol was added to the cell culture medium to aid 
in maintaining a reducing environment; limiting toxic oxygen radicals. All cultures were incubated at 37 °C with 
5% CO2 until they reached 70–80% confluency. Culture medium was changed every other day to enhance cell 
growth and viability.
Seeding beta-cells within micro-wells. Micro-molds (Sigma-Aldrich, UK) were used for casting 
3-dimensional (3D) culture plates by adding 500 µL of 2 w/v% agarose solution into each mold. The final transpar-
ent agarose culture plate with 400 µm diameter micro-wells (number of micro-wells per mold: 256) were removed 
from the mold after being cooled. Cells were first trypsinized with trypsin-EDTA (Sigma, UK), and counted with 
a haemocytometer. MIN-6 cells suspended in supplemented DMEM, at a density of 5 × 105cells/200 µL, were 
seeded on top of the concave agarose micro-wells. Spheroid formation was observed daily using an inverted 
microscope (Olympus Co., Germany), and formed spheroids were used for further studies after being cultured 
for 4–5 days (Fig. 1a).
Size analysis of MIN-6 spheroids. The size of the MIN-6 cell spheroids formed in micro-wells were 
compared with the same concentration of cells (2.5 × 106 cells/mL) seeded on flat-bottomed non-attachable cul-
ture plates. The average diameters of the two groups were determined on day 7 of culture from thirty randomly 
selected samples, which were observed using a light microscope (Olympus Co., Germany). Quantitative data was 
determined using Image J software (NIH, Bethesda, MD, USA).
Coating MIN-6 spheroids with multi-polyelectrolyte layers. After 4–5 days of culture, cell sphe-
roids were retrieved from the agarose micro-wells using a plate shaker (Grant-bio, PMS-1000i, UK) (450 rpm). 
Solutions of alginate (1 mg/mL) (ALG, medium viscosity (≫20,000 cP, Sigma, UK) and Poly-l-lysine (1 mg/mL) 
(PLL, MW: 30,000–70,000, Sigma, UK) were prepared in deionised water and Phosphate buffered saline (PBS, 
Fisher Scientific, UK), respectively. All solutions were sterile filtered using a 0.22 µm syringe filter (Millipore, 
USA) and UV sterilised overnight. Contrary to the conventional layer-by-layer deposition, before starting the 
coating process cell spheroids were first suspended in 200 µl of CaCl2 (100 mM). After washing with PBS, 200 µL 
of alginate was added to minimise the potential toxicity of direct contact between cells surface and cationic poly-
mer (PLL). Alternating layers of PLL and alginate were then applied according to conventional LBL methods24,25. 
Briefly, 200 µl of PLL was added to the pre-coated spheroids, after 4 min deposition time, cells were washed twice 
in 500 µl PBS to remove any unbound PLL, followed by the addition of the anionic polymer (alginate) with the 
same procedure. The last two steps were repeated to achieve the desired number of layers. Finally, cells were 
washed three times with DMEM and were incubated at 37 °C for further studies.
Fluorescent labelling of PLL. To prepare the fluorescently labelled PLL, 0.1 mg of Alexa Fluor 647NHS 
ester (Succinimidyl Ester) (Thermo Fisher, UK) was dissolved in 1 mL of dimethyl sulfoxide (DMSO, Sigma, 
UK). 100 µL of the dye was added to 1 mL of PLL stock solution with a concentration of 2 mg/mL. The solution 
was incubated at room temperature for 6 h under continuous stirring. To remove the excess dye, the solution was 
then dialyzed for 24 h against deionised water. The final solution was then kept in the dark at 4 °C until needed.
Assessment of cell viability and metabolic activity. Viability of coated MIN-6 cells using different 
coating deposition sequence was evaluated using a live/dead staining kit. Briefly on the day of experimentation, 
1 µL of calcein acetoxymethylester (Calcein AM (662 Da), indicator for live cells, Invitrogen, USA) and 5 µL of 
propidium iodide (PI (668 Da), indicator for dead cells, Invitrogen, UK) were added to a 200 µL suspension of 
coated spheroids in cell culture medium. Cells were incubated in the dark at 37 °C for 30 min. Stained cells were 
then visualised using confocal laser scanning microscopy (Olympus FV1000, Multiple Ar laser, Germany), and 
images were analysed using ImageJ software (NIH, USA).
The metabolic activities of coated and non-coated (control) MIN-6 cells were assessed using the Alamar Blue 
cell proliferation assay (Thermo Fisher, UK). The assay reagent reduces from a non-fluorescent blue colour to a 
fluorescent red form, during cellular metabolism. Hence, the amount of assay reagent reduction is proportional 
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to cell number (presuming equal metabolic activity). Briefly, 20 µL of Alamar Blue reagent were added to 200 µL 
of cell spheroids suspension in DMEM, followed by incubating for 4 h at 37 °C. The fluorescence was then read 
(590 nm emission and 560 nm excitation) using a microplate reader (GloMax-Multi+, Promega, USA). The 
results were reported as percentage reduction between the coated and the control sample.
Immunofluorescent staining. After 5 days in culture, MIN-6 spheroids were fixed with 10% formalin 
(Sigma, UK). Samples were then blocked in PBS solution containing 2% bovine serum albumin (BSA, Sigma, 
UK) and 0.2% Triton X-100 (Sigma, UK) for 1 h. After washing in PBS, fixed cells were stained with Actin-red 555 
(F-actin Probe, Life Technologies, UK) for 30 min, followed by several washing steps with PBS. Cell nuclei were 
also counter-stained using DAPI (1 µg/mL) (Sigma, UK). 3D visualisation of the stained spheroids was under-
taken using confocal microscopy (Laser 405 nm: DAPI, Laser 543: Actin-red 555).
Antibody exclusion assay. The permeability of the coated spheroids against large immunologically rel-
evant molecules was evaluated using FITC labelled anti-mouse MHC class II (eBioscience, UK). Briefly, cell 
spheroids with and without coating layers were prepared as described previously. Fifteen MIN-6 spheroids were 
randomly selected from each group, and 100 µL of 2% BSA and Hanks’ balanced salt solution (HBSS, blocking 
buffer, Sigma, UK) were added to the samples. Cells were incubated for 15 min at 37 °C with 1 µL of FITC- anti-
body. Samples were then washed twice with HBSS and 0.1% Tween-20 to remove any excess antibody. The coated 
and non-coated spheroids were observed using confocal laser scanning microscopy with an argon laser.
Treating MIN-6 cells with cytokines. Groups of coated and non-coated spheroids were treated with 
a mixture of three cytokines at a final concentration of Interleukin-1β (IL-1β, Sigma, UK) (5 ng/mL), mouse 
tumour necrosis factor-α (TNF-α, Gibco, Life Technology, UK) (10 ng/mL), and mouse interferon-ϒ (IFN-ϒ, 
Gibco, Life Technology, UK) (100 ng/mL) in DMEM. All treated samples were incubated overnight at 37 °C. The 
viability of the treated spheroids was measured using the Alamar Blue assay as described previously, and data 
were normalised to 1000 cells.
Glucose-stimulated insulin secretion (GSIS) assay. To evaluate the function of MIN-6 cells, the 
amount of insulin secreted from non-coated and coated cells in response to changes in glucose concentration was 
measured. Briefly, samples were washed and pre-incubated in Krebs-Ringer bicarbonate buffer (KRBH: 125 mM 
NaCl, 1.2 mM MgSO4, 1.2 mM CaCl2, 22 mM NaHCO3, 10 mM HEPES, 1.19 mM KH2PO4) + 0.1% BSA with glu-
cose concentration of 2 mM for 2 h. Then, samples underwent a static incubation for 1 h with low (2 mM) glucose 
concentration in KRBH + 0.1% BSA followed incubation for a further hour in high (20 mM) glucose concentra-
tion KRBH + 0.1% BSA as the stimulator. For each incubation period the cultured supernatant was collected for 
insulin assay and diluted to the appropriate range based on the assay standard curve. The secreted insulin was 
measured using an Enzyme-linked immunosorbent assay (ELISA) kit (Millipore, UK), and the colorimetric reac-
tion was quantified using a plate spectrophotometer (GloMax-Multi + Mictoplate Multimode reader, Promega, 
USA) at a wavelength of 450 nm.
Statistical analysis. The student’s t-test, assuming equal variance, was used to identify any significant dif-
ferences between pairs of groups. One-way analysis of variance (ANOVA) was used to identify any significant 
difference between the means of independent groups. Furthermore, a Bonferroni post-hoc test was performed 
with ANOVA to find means that were significantly different within groups. A P-value < 0.05 was determined as 
significant. Results are presented as mean ± standard deviation unless otherwise stated.
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Abstract 
This study presents experimental data of a fluidised-bed bioreactor for the cultivation of encapsulated 
pancreatic beta-cells. The fluidisation quality for the bioreactor was evaluated at different flow rate 
using bed-expansion parameters. Homogeneous distribution of microcapsules was achieved at a flow 
rate of 2000 µL/min. This enabled efficient contact between the encapsulated cells and medium, 
which contributed to high cell viability. Microcapsule breakage was < 4% on day 7 and confirmed the 
stability of encapsulated systems under fluidised culture. Importantly, endocrine beta-cells cultured in 
the bioreactor were shown to be dramatically more responsive to changes in glucose concentration 
compared to static culture (P< 0.001). Based on these results, cultivation of encapsulated cells in a 
fluidised bioreactor, especially for pancreatic beta-cells that are limited in supply, is a promising 
approach to address the lack of a safe method for storage and handling of cells between laboratories 
and clinical sites prior to transplantation. 
Keywords: microcapsules, endocrine beta-cells, bioreactor, viability, fluidisation, insulin secretion. 
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